SUNS - South North Development Monitor
     INDEX        ARCHIVE        SEARCH        FROM GATT TO THE WTO        ABOUT
SUNS # 8996 Monday 14 October 2019

Health : MSF launches global campaign to lower price of crucial TB drug   (Kanaga Raja, Geneva) (PRIV)
(, )
The medical humanitarian organisation Medecins Sans Frontieres (MSF) has launched a global campaign on 10 October that calls on pharmaceutical giant Johnson & Johnson (J&J) to lower the price of its life-saving anti-tuberculosis (TB) drug bedaquiline to no more than US$1 per day for everyone who needs it.

UN : Aid groups warn of humanitarian crisis from Turkey's assault on Syria   (IPS, New York) (PRIV)
(, )
Aid groups operating in northeastern Syria have been raising the alarm about civilian casualties and an impending humanitarian crisis this week, as Turkey began a military assault on the turbulent region's Kurdish militants.

Opinion : The role of emerging technologies in military conflicts   (IPS, Stockholm) (PRIV)
(, )
Throughout history, technology has transformed armed conflict.

Opinion : Austerity, the "new normal"   (IPS, Washington DC) (PRIV)
(, )
While this week Ministers of Finance and economists meet in Washington to confront global economic challenges at the IMF and World Bank Annual Meetings, the majority of the world population lives with austerity cuts and see their living standards deteriorating.

  About   Publisher: Third World Network, 131 Jalan Macalister, 10400 penang, malaysia
Editor emeritus: chakravarthi raghavan.
Editor: kanaga raja, rm c508, 8-14 Avenue de la Paix, ch-1211 geneva 10, switzerland; tel:(4122) 7344274, fax 7401672; email:
Advisory board: rajiv kumar chander, triyono wibowo
As a non-profit service, subscriptions are intended to cover or contribute to costs of operations. terms and special conditions: information available from publisher.


[c] 2013, SUNS - All rights reserved. May not be reproduced, reprinted or posted to any system or service without specific permission from SUNS. This limitation includes incorporation into a database, distribution via Usenet News, bulletin board systems, mailing lists, print media or broadcast. For information about reproduction or multi-user subscriptions please contact <>